The CADF’s role is to define and implement the doping control strategy on behalf of UCI and conduct a comprehensive in- and out-of-competition testing program to detect prohibited substances and methods. Doping controls are carried out in compliance with UCI regulations and WADA regulations, standards and technical documents.

The CADF’s mandate is to develop and implement an effective, intelligent and proportionate Test Distribution Plan (TDP) based on a comprehensive risk assessment. Such TDP prioritizes appropriately between disciplines, categories of Riders, types of Testing, types of Samples collected, and types of Sample analysis.

Blood and urine samples may be collected during a race, preparation/training periods or during the off-season.

Riders should expect to be required to provide a blood or urine sample at anytime and anywhere.

All samples will be collected by qualified Doping Control Officers (DCOs) and Blood Collection Officers (BCOs) appointed by CADF, Sample Collection Agencies or National Anti-Doping Organisations (NADOs). All relevant doping control forms information is entered into ADAMS and CADF coordinates and supervises the operations of all actors involved in the process.

In this regard and in addition to screening for banned substances, any sample collected by the CADF can also be analyzed in the scope of the ABP Program as follows:

• Blood tests collected for the purposes of the haematological profile
• Urine tests collected for the purposes of the steroid profile.

The samples are analyzed by WADA Accredited Laboratories according the WADA International Standards for Laboratories.

The CADF cooperates with NADOS for the implementation of In-Competition and Out-of-Competition testing plans.

For more information about testing, please click on the following link:

• WADA International Standard for Testing and Investigations (ISTI)
• UCI TIR (Testing and Investigation Regulation)
• WADA Standards for Laboratories (ISL)
• WADA Technical Document for Sport Specific Analysis (TDSSA)